本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Prana生物工艺

2.06
+0.0000
成交量:- -
成交额:- -
市值:1,948.14万
市盈率:-2.61
高:2.06
开:2.06
低:2.06
收:2.06
数据加载中...
2021/01/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/19

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/09/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/07/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/12/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/04/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/27

非美公司披露报告

[Amend] Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]